| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-05-13 17:03:59 -0600 |
| HMDB ID |
HMDB00574 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
L-Cysteine |
| Description |
Cysteine is a naturally occurring, sulfur-containing amino acid that is found in most proteins, although only in small quantities. Cysteine is unique amongst the twenty natural amino acids as it contains a thiol group. Thiol groups can undergo oxidation/reduction (redox) reactions; when cysteine is oxidized it can form cystine, which is two cysteine residues joined by a disulfide bond. This reaction is reversible: as reduction of this disulphide bond regenerates two cysteine molecules. The disulphide bonds of cystine are crucial to defining the structures of many proteins. Cysteine is often involved in electron-transfer reactions, and help the enzyme catalyze its reaction. Cysteine is also part of the antioxidant glutathione. N-acetyl-L-cysteine (NAC) is a form of cysteine where an acetyl group is attached to cysteine's nitrogen atom and is sold as a dietary supplement. Cysteine is named after cystine, which comes from the Greek word kustis meaning bladder - cystine was first isolated from kidney stones. As cysteine contains a sulphydryl group, it can undergo redox reactions. Oxidation of cysteine can produce a disulfide bond with another thiol, or further oxidation can produce sulphfinic or sulfonic acids. The cysteine thiol group is also a nucleophile and can undergo addition and substitution reactions. Thiol groups become much more reactive when they are ionized, and cysteine residues in proteins have pKa values close to neutrality, so are often in their reactive thiolate form in the cell. The thiol group also has a high affinity for heavy metals and proteins containing cysteine will bind metals such as mercury, lead and cadmium tightly. Due to this ability to undergo redox reactions, cysteine has antioxidant properties. Cysteine is an important source of sulfur in human metabolism, and although it is classified as a non-essential amino acid, cysteine may be essential for infants, the elderly, and individuals with certain metabolic disease or who suffer from malabsorption syndromes. Cysteine may at some point be recognized as an essential or conditionally essential amino acid. (http://en.wikipedia.org/wiki/Cysteine). Cysteine is important in energy metabolism. As cystine, it is a structural component of many tissues and hormones. Cysteine has clinical uses ranging from baldness to psoriasis to preventing smoker's hack. In some cases, oral cysteine therapy has proved excellent for treatment of asthmatics, enabling them to stop theophylline and other medications. Cysteine also enhances the effect of topically applied silver, tin and zinc salts in preventing dental cavities. In the future, cysteine may play a role in the treatment of cobalt toxicity, diabetes, psychosis, cancer and seizures. (http://www.dcnutrition.com/AminoAcids/). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (+)-2-Amino-3-mercaptopropionic acid
- (2R)-2-amino-3-mercaptopropanoate
- (2R)-2-amino-3-mercaptopropanoic acid
- (2R)-2-amino-3-sulfanylpropanoate
- (2R)-2-amino-3-sulfanylpropanoic acid
- (R)-(+)-cysteine
- (R)-2-amino-3-mercapto-Propanoate
- (R)-2-amino-3-mercapto-Propanoic acid
- (R)-2-Amino-3-mercaptopropanoate
- (R)-2-Amino-3-mercaptopropanoic acid
- (R)-cysteine
- 2-Amino-3-mercaptopropanoate
- 2-Amino-3-mercaptopropanoic acid
- 2-Amino-3-mercaptopropionate
- 2-Amino-3-mercaptopropionic acid
- 3-Mercapto-L-Alanine
- Acetylcysteine
- alpha-Amino-beta-thiolpropionic acid
- B-Mercaptoalanine
- beta-Mercaptoalanine
- Carbocysteine
- Cisteina
- Cisteinum
- Cystein
- Cysteine
- Cysteinum
- Free cysteine
- Half-cystine
- L Cysteine
- L-(+)-Cysteine
- L-2-Amino-3-mercaptopropanoate
- L-2-Amino-3-mercaptopropanoic acid
- L-2-Amino-3-mercaptopropionic acid
- L-Cystein
- L-Cysteine
- Polycysteine
- Thioserine
|
| Chemical Formula |
C3H7NO2S |
| Average Molecular Weight |
121.158 |
| Monoisotopic Molecular Weight |
121.019749163 |
| IUPAC Name |
(2R)-2-amino-3-sulfanylpropanoic acid |
| Traditional IUPAC Name |
L-cysteine |
| CAS Registry Number |
52-90-4 |
| SMILES |
N[C@@H](CS)C(O)=O |
| InChI Identifier |
InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1 |
| InChI Key |
XUJNEKJLAYXESH-REOHCLBHSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Amino Acids and Derivatives |
| Sub Class |
Alpha Amino Acids and Derivatives |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- Common amino acids(KEGG)
- cysteine zwitterion(ChEBI)
|
| Substituents |
- Alkylthiol
- Carboxylic Acid
- Primary Aliphatic Amine (Alkylamine)
- Thiol (Sulfanyl Compound)
|
| Direct Parent |
Alpha Amino Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Cysteine metabolism
- Component of Glycine, serine and threonine metabolism
- Component of Methionine metabolism
- Component of Nitrogen metabolism
- Component of Selenoamino acid metabolism
- Component of Taurine and hypotaurine metabolism
|
| Application |
Not Available |
| Cellular locations |
- Cytoplasm
- Extracellular
- Mitochondria
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
220 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
277 mg/mL at 25 °C |
BEILSTEIN |
| LogP |
-2.49 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
| Gas-MS Spectrum |
| 13C NMR Spectrum |
| 1H NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies ) |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm
- Extracellular
- Mitochondria
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
- Muscle
- Skeletal Muscle
- Fibroblasts
- Intestine
- Neuron
- Placenta
- Testes
- Kidney
- Epidermis
- Thyroid Gland
- Myelin
- Prostate
- Adrenal Cortex
- Platelet
- Spleen
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
197.00 +/- 56.00 uM |
Adolescent (13-18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
131.00 +/- 40.00 uM |
Infant (0-1 year old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
210.00 +/- 40.00 uM |
Children (1-13 year old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
212.00 +/- 23.00 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
52.0 (41.0-63.0) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
33.5 +/- 10.3 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.054 (0.017-0.108) uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
3.322 (1.447-5.197) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
30.32 +/- 24.58 umol/mmol creatinine |
Infant (0-1 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
81.0 (36.7-147.6) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
by HPLC-FLD
|
| Urine |
Detected and Quantified |
|
32.00 +/- 10.00 umol/mmol creatinine |
Infant (0-1 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
28.00 +/- 9.00 umol/mmol creatinine |
Children (1-13 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
34.4 +/- 11.00 umol/mmol creatinine |
Adolescent (13-18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
33.4 +/- 15.5 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
65.8 (23.1-134.5) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
urine by NMR
|
| Urine |
Detected and Quantified |
|
14.9 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.355 (0.157-1.146) uM |
Adult (>18 years old) |
Not Specified |
Multiple sclerosis |
Not Available |
| Blood |
Detected and Quantified |
|
0.420 (0.154-0.874) uM |
Adult (>18 years old) |
Not Specified |
Stroke |
Not Available |
| Blood |
Detected and Quantified |
|
0.415 (0.199-1.038) uM |
Adult (>18 years old) |
Not Specified |
Peripheral neuropathy |
Not Available |
| Blood |
Detected and Quantified |
|
0.491 (0.247-1.764) uM |
Adult (>18 years old) |
Not Specified |
Dementia (Alzheimer's and non-Alzheimer's) |
Not Available |
| Blood |
Detected and Quantified |
|
13.0 (10.0-16.0) uM |
Adult (>18 years old) |
Both |
AIDS |
Not Available |
| Blood |
Detected and Quantified |
|
12.81 +/- 2.17 uM |
Elderly (>65 years old) |
Both |
Alzheimer's Disease |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.042 (0.022-0.10) uM |
Adult (>18 years old) |
Not Specified |
Multiple sclerosis |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.048 (0.018-0.10) uM |
Adult (>18 years old) |
Not Specified |
Stroke |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.034 (0.018-0.075) uM |
Adult (>18 years old) |
Not Specified |
Peripheral neuropathy |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.047 (0.025-0.125) uM |
Adult (>18 years old) |
Not Specified |
Dementia (Alzheimer's and non-Alzheimer's) |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| AIDS |
- Naisbitt DJ, Vilar FJ, Stalford AC, Wilkins EG, Pirmohamed M, Park BK: Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection. AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1929-38.
Pubmed: 11153075
|
| Multiple sclerosis |
- Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W: Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin Chem. 2007 Jun;53(6):1129-36. Epub 2007 Mar 23.
Pubmed: 17384003
|
| Stroke |
- Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W: Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin Chem. 2007 Jun;53(6):1129-36. Epub 2007 Mar 23.
Pubmed: 17384003
|
| Peripheral neuropathy |
- Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W: Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin Chem. 2007 Jun;53(6):1129-36. Epub 2007 Mar 23.
Pubmed: 17384003
|
| Dementia |
- Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W: Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin Chem. 2007 Jun;53(6):1129-36. Epub 2007 Mar 23.
Pubmed: 17384003
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
DB00151  |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB012678 |
| KNApSAcK ID |
C00001351  |
| Chemspider ID |
5653  |
| KEGG Compound ID |
C00097  |
| BioCyc ID |
CYS  |
| BiGG ID |
33843  |
| Wikipedia Link |
L-Cysteine  |
| NuGOwiki Link |
HMDB00574  |
| Metagene Link |
HMDB00574  |
| METLIN ID |
5556  |
| PubChem Compound |
5862  |
| PDB ID |
CYS  |
| ChEBI ID |
17561  |
| References |
| Synthesis Reference |
Kumagai, Hidehiko; Tanaka, Hideyuki; Sejima, Shunsuke; Yamada, Hideaki. Elimination and replacement reactions of b-chloro-L-alanine by cysteine desulfhydrase from Aerobacter aerogenes. Agricultural and Biological Chemistry (1977), 41(10), 2071-5. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Sandmann J, Schwedhelm KS, Tsikas D: Specific transport of S-nitrosocysteine in human red blood cells: Implications for formation of S-nitrosothiols and transport of NO bioactivity within the vasculature. FEBS Lett. 2005 Aug 1;579(19):4119-24.
Pubmed: 16023102
- Paivalainen S, Suokas M, Lahti O, Heape AM: Degraded myelin-associated glycoprotein (dMAG) formation from pure human brain myelin-associated glycoprotein (MAG) is not mediated by calpain or cathepsin L-like activities. J Neurochem. 2003 Feb;84(3):533-45.
Pubmed: 12558973
- Iyer S, Leonidas DD, Swaminathan GJ, Maglione D, Battisti M, Tucci M, Persico MG, Acharya KR: The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution. J Biol Chem. 2001 Apr 13;276(15):12153-61. Epub 2000 Nov 7.
Pubmed: 11069911
- Nishiya Y, Yoshida Y, Yoshimura M, Fukamachi H, Nakano Y: Homogeneous enzymatic assay for L-cysteine with betaC-S lyase. Biosci Biotechnol Biochem. 2005 Nov;69(11):2244-6.
Pubmed: 16306712
- Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002 Sep;18(9):761-6.
Pubmed: 12297216
- Santamaria I, Velasco G, Cazorla M, Fueyo A, Campo E, Lopez-Otin C: Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. Cancer Res. 1998 Apr 15;58(8):1624-30.
Pubmed: 9563472
- Eriksson A, Tohonen V, Wedell A, Nordqvist K: Isolation of the human testatin gene and analysis in patients with abnormal gonadal development. Mol Hum Reprod. 2002 Jan;8(1):8-15.
Pubmed: 11756564
- Kaminska J, Wisniewska A, Koscielak J: Chemical modifications of alpha1,6-fucosyltransferase define amino acid residues of catalytic importance. Biochimie. 2003 Mar-Apr;85(3-4):303-10.
Pubmed: 12770769
- Li Y, Gamper N, Shapiro MS: Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent. J Neurosci. 2004 Jun 2;24(22):5079-90.
Pubmed: 15175377
- Lindzen M, Gottschalk KE, Fuzesi M, Garty H, Karlish SJ: Structural interactions between FXYD proteins and Na+,K+-ATPase: alpha/beta/FXYD subunit stoichiometry and cross-linking. J Biol Chem. 2006 Mar 3;281(9):5947-55. Epub 2005 Dec 21.
Pubmed: 16373350
- Norris FA, Wilson MP, Wallis TS, Galyov EE, Majerus PW: SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14057-9.
Pubmed: 9826652
- Kersemans V, Cornelissen B, Kersemans K, Bauwens M, Achten E, Dierckx RA, Mertens J, Slegers G: In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT. J Nucl Med. 2005 Mar;46(3):532-9.
Pubmed: 15750170
- Foss CA, Mease RC, Fan H, Wang Y, Ravert HT, Dannals RF, Olszewski RT, Heston WD, Kozikowski AP, Pomper MG: Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Clin Cancer Res. 2005 Jun 1;11(11):4022-8.
Pubmed: 15930336
- Nicholson JK, O'Flynn MP, Sadler PJ, Macleod AF, Juul SM, Sonksen PH: Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J. 1984 Jan 15;217(2):365-75.
Pubmed: 6696735
- Kozaki K, Miyaishi O, Asai N, Iida K, Sakata K, Hayashi M, Nishida T, Matsuyama M, Shimizu S, Kaneda T, et al.: Tissue distribution of ERp61 and association of its increased expression with IgG production in hybridoma cells. Exp Cell Res. 1994 Aug;213(2):348-58.
Pubmed: 8050492
- Amberger VR, Hensel T, Ogata N, Schwab ME: Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res. 1998 Jan 1;58(1):149-58.
Pubmed: 9426071
- Zhang JT, Li QX, Wang D, Zhu ZL, Yang YH, Cui DS, Wang MW, Sun XF: Up-regulation of PINCH in the stroma of oral squamous cell carcinoma predicts nodal metastasis. Oncol Rep. 2005 Dec;14(6):1519-22.
Pubmed: 16273248
- Taveau M, Bourg N, Sillon G, Roudaut C, Bartoli M, Richard I: Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol Cell Biol. 2003 Dec;23(24):9127-35.
Pubmed: 14645524
- Yu FH, Westenbroek RE, Silos-Santiago I, McCormick KA, Lawson D, Ge P, Ferriera H, Lilly J, DiStefano PS, Catterall WA, Scheuer T, Curtis R: Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. J Neurosci. 2003 Aug 20;23(20):7577-85.
Pubmed: 12930796
- Naisbitt DJ, Vilar FJ, Stalford AC, Wilkins EG, Pirmohamed M, Park BK: Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection. AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1929-38.
Pubmed: 11153075
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
Pubmed: 19212411
|
| Enzymes |
|
|
|
|
| Name: |
Aminopeptidase N
|
| Reactions: |
- Release of an N-terminal amino acid, Xaa!Yaa- from a peptide, amide or arylamide. Xaa is preferably Ala, but may be most amino acids including Pro (slow action). When a terminal hydrophobic residue is followed by a prolyl residue, the two may be released as an intact Xaa-Pro dipeptide ALL_REAC (other) R00899 R04951 COFACTOR Manganese [CPD:C00034]
- Zinc [CPD:C00038]
|
| Gene Name: |
ANPEP |
| Uniprot ID: |
P15144  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
| Name: |
Cystathionine gamma-lyase
|
| Reactions: |
- (1) L-cystathionine + H2O = L-cysteine + NH3 + 2-oxobutanoate (overall reaction) [RN:R01001]
- (2) (1a) L-cystathionine = L-cysteine + 2-ammoniobut-2-enoate [RN:R08632]
- (3) (1b) 2-ammoniobut-2-enoate + H2O = 2-oxobutanoate + NH3 (spontaneous) [RN:R08637]
|
| Gene Name: |
CTH |
| Uniprot ID: |
P32929  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
| Name: |
Glutathione synthetase
|
| Reactions: |
- ATP + gamma-L-glutamyl-L-cysteine + glycine = ADP + phosphate + glutathione [RN:R00497]
|
| Gene Name: |
GSS |
| Uniprot ID: |
P48637  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Cytosol aminopeptidase
|
| Reactions: |
- Release of N-terminal proline from a peptide ALL_REAC (other) R00135 COFACTOR Manganese [CPD:C00034]
|
| Gene Name: |
LAP3 |
| Uniprot ID: |
P28838  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name: |
Prenylcysteine oxidase 1
|
| Reactions: |
- an S-prenyl-L-cysteine + O2 + H2O = a prenal + L-cysteine + H2O2 [RN:R07360]
|
| Gene Name: |
PCYOX1 |
| Uniprot ID: |
Q9UHG3  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|